Teeling Smith, G. ed.

July 1965

Based on a series of six lectures discussing some of the special considerations which arise when a science based industry has the government as a major customer in its home market, with particular reference to the relationship between the pharmaceutical industry and the National Health Service. The book challenges conventional attitudes to costing, pricing and marketing which in the past have been applied to science-based industry. The first paper discusses the influence of patents on the pattern of progress.

May 1963

Britain is not unique in having a health service. Practically every European country has accepted the provision of medical care as a community responsibility. Amongst the sixteen countries in Western Europe, only the Finns have not yet introduced an extensive compulsory pre-payment scheme of some sort and they are to do so in 1964.


Subscribe to RSS - Monograph